Form D — Mekiri Bio, Inc.
0002088062-25-000002 · filed 2025-10-16
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,000,000
- Total sold
- $1,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Mekiri Bio, Inc.
- CIK
- 2088062
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 68 HARRISON AVENUE
BOSTON, MA 02111 - Phone
- 617-203-8458
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Debbie Lin · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Anita DiFazio · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Corey McCann · DirectorBoston, MA Find on LinkedIn ↗
-
Aaron DiAntonio · DirectorBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.